29 results on '"Retel, Valesca P."'
Search Results
2. The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions
3. Health state utility and health-related quality of life measures in patients with advanced ovarian cancer
4. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma
5. Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe
6. A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice
7. Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer
8. Duty to recontact in genomic cancer care: a tool helping to assess the professional’s responsibility
9. Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial
10. The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
11. The tip of the iceberg? Budget restrictions and patient perspectives on cancer drug costs: An international survey in 29 hospitals and 56 patient organizations
12. Impact of organ-on-a-chip technology on pharmaceutical R&D costs
13. Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review
14. Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis
15. Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy
16. Value of Research and Value of Development in Early Assessments of New Medical Technologies
17. Review on early technology assessments of nanotechnologies in oncology
18. Costs, throughput time, and proportion of valid test results, a model-based analysis of liquid biopsies for stage IV non-small cell lung cancer.
19. Disparities in surveillance imaging after breast conserving surgery for primary DCIS.
20. Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature
21. Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room.
22. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
23. Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room
24. The validity and predictive value of blood-based biomarkers in prediction of response in the treatment of non-small cell lung cancer: A systematic review.
25. Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: Evaluation of its early cost-effectiveness.
26. Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial
27. Knowledge of genomic testing among early-stage breast cancer patients
28. An update on the PERISCOPE II trial; A multicentre RCT comparing gastrectomy, CRS and HIPEC to systemic chemotherapy alone for gastric cancer patients with limited peritonitis carcinomatosis.
29. Tumour tissue: who is in control?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.